Showing results (2101-2110 of 27,558) with videos related to

Sort By:
Pageof 2,756
Endocrinology|November 23, 2000
A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1B A Scaglione-Sewell, M Bissonnette, S Skarosi, et al.
Endocrinology|November 23, 2000
Inhibition of osteoblast differentiation by tumor necrosis factor-alphaL Gilbert, X He, P Farmer, et al.
Endocrinology|November 23, 2000
Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart modelF Weekers, E Van Herck, J Isgaard, et al.
Endocrinology|November 23, 2000
Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic miceR A Memon, L H Tecott, K Nonogaki, et al.
Endocrinology|November 23, 2000
Characterization of purinergic receptors and receptor-channels expressed in anterior pituitary cellsT A Koshimizu, M Tomić, A O Wong, et al.
Endocrinology|November 23, 2000
Cholestenoic acid is a naturally occurring ligand for liver X receptor alphaC Song, S Liao
Endocrinology|November 23, 2000
p38MAPK inhibition enhances basal and norepinephrine-stimulated p42/44MAPK phosphorylation in rat pinealocytesM Mackova, J R Man, C L Chik, et al.
Endocrinology|November 23, 2000
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humansY Date, M Kojima, H Hosoda, et al.
Endocrinology|December 7, 2000
Retinoic acids and thyroid hormone act synergistically with dexamethasone to increase growth hormone-releasing hormone receptor messenger ribonucleic acid expressionH Nogami, M Matsubara, T Harigaya, et al.
Endocrinology|December 7, 2000
Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axesP D Raposinho, E Castillo, V d'Alleves, et al.
Pageof 2,756